
ResMed RMD
€ 208.62
1.75%
Geschäftsbericht 2022
hinzugefügt 12.08.2022
ResMed EV 2011-2026 | RMD
EV Jährlich ResMed
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.5 B | 37.3 B | 29.2 B | 20.5 B | 15.8 B | 11.6 B | 10.5 B | 7.76 B | 7.03 B | 6.42 B | 4.35 B | 4.22 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 37.3 B | 4.22 B | 15.9 B |
EV anderer Aktien in der Medizinische Instrumente
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | ||
|
Baxter International
BAX
|
34.3 B | $ 19.51 | 2.12 % | $ 9.95 B | ||
|
Becton, Dickinson and Company
BDX
|
55.5 B | $ 195.0 | 0.49 % | $ 56.1 B | ||
|
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | ||
|
Ekso Bionics Holdings
EKSO
|
17.1 M | $ 8.13 | -5.9 % | $ 164 M | ||
|
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | ||
|
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | ||
|
Harvard Bioscience
HBIO
|
248 M | $ 0.66 | -0.9 % | $ 28 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | ||
|
Repro Med Systems
KRMD
|
93.3 M | $ 5.58 | -3.96 % | $ 254 M | ||
|
Alcon
ALC
|
7.12 B | $ 77.69 | -1.42 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
1.93 B | $ 39.19 | -0.94 % | $ 1.84 B | ||
|
Merit Medical Systems
MMSI
|
6.6 B | $ 86.9 | -1.41 % | $ 5.06 B | ||
|
ICU Medical
ICUI
|
3.34 B | $ 139.1 | -2.5 % | $ 3.39 B | ||
|
electroCore
ECOR
|
-1.64 M | $ 4.54 | 1.23 % | $ 25 K | ||
|
iRhythm Technologies
IRTC
|
3.91 B | $ 175.59 | -1.04 % | $ 5.48 B | ||
|
AngioDynamics
ANGO
|
396 M | $ 12.64 | -1.56 % | $ 516 M | ||
|
Isoray
ISR
|
13.3 M | - | 0.03 % | $ 108 M | ||
|
The Cooper Companies
COO
|
20.4 B | $ 81.37 | -0.72 % | $ 16.2 B | ||
|
Nephros
NEPH
|
21.7 M | $ 4.78 | -2.15 % | $ 49.6 M | ||
|
Glaukos Corporation
GKOS
|
4.69 B | $ 111.02 | -1.67 % | $ 5.38 B | ||
|
LeMaitre Vascular
LMAT
|
2.26 B | $ 80.78 | -0.39 % | $ 1.81 B | ||
|
Haemonetics Corporation
HAE
|
2.76 B | $ 80.15 | - | $ 4.03 B | ||
|
InfuSystem Holdings
INFU
|
197 M | $ 8.46 | -5.58 % | $ 175 M | ||
|
Masimo Corporation
MASI
|
10.4 B | $ 127.63 | -1.87 % | $ 6.8 B | ||
|
Intuitive Surgical
ISRG
|
203 B | $ 562.18 | -0.74 % | $ 200 B | ||
|
OraSure Technologies
OSUR
|
60.6 M | $ 2.37 | -2.27 % | $ 176 M | ||
|
Microbot Medical
MBOT
|
13.1 M | $ 2.09 | 4.69 % | $ 21.3 M | ||
|
Milestone Scientific
MLSS
|
70.1 M | $ 0.29 | 6.23 % | $ 23.1 M | ||
|
STERIS plc
STE
|
27.5 B | $ 251.21 | -0.91 % | $ 24.8 B | ||
|
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
2.61 B | $ 21.74 | 0.09 % | $ 3.74 B | ||
|
Stereotaxis
STXS
|
216 M | $ 2.32 | 0.65 % | $ 187 M | ||
|
Pro-Dex
PDEX
|
175 M | $ 37.63 | -2.21 % | $ 124 M | ||
|
Predictive Oncology
POAI
|
12.7 M | - | - | $ 32.4 M | ||
|
Pulse Biosciences
PLSE
|
389 M | $ 13.26 | -3.46 % | $ 637 M | ||
|
Utah Medical Products
UTMD
|
162 M | $ 57.34 | 2.47 % | $ 208 M | ||
|
DENTSPLY SIRONA
XRAY
|
7.04 B | $ 11.33 | -0.87 % | $ 2.3 B | ||
|
Repligen Corporation
RGEN
|
126 M | $ 163.5 | -0.22 % | $ 9.11 M | ||
|
BioLife Solutions
BLFS
|
1.09 B | $ 23.86 | -1.32 % | $ 1.1 B | ||
|
Retractable Technologies
RVP
|
90.3 M | $ 0.77 | -0.7 % | $ 23.1 M | ||
|
STAAR Surgical Company
STAA
|
800 M | $ 23.45 | 1.56 % | $ 1.15 B | ||
|
Teleflex Incorporated
TFX
|
8.74 B | $ 123.04 | 0.79 % | $ 5.76 B | ||
|
West Pharmaceutical Services
WST
|
15.9 B | $ 276.44 | 0.44 % | $ 20.2 B |